Exchange of Information between the Parties. Subject to the obligations of confidentiality set forth in this Agreement and promptly following the Effective Date, DTI shall provide to ▇▇▇▇▇▇▇ all material documents in DTI's possession as of the Effective Date describing preclinical, clinical, chemical, pharmacological, toxicological, assay, control, and manufacturing data and other information which is useful for development, registration and commercialization of Licensed Products in the Territory, obtained by DTI in its study of Licensed Products. Following the Effective Date, each party shall own all data generated by such party and agrees to provide the other with all material information available to such party concerning the Licensed Products, subject to any contractual restrictions on disclosure.
Appears in 3 contracts
Sources: Exclusive License Agreement (Aderis Pharmaceuticals Inc), Exclusive License Agreement (Aderis Pharmaceuticals Inc), Exclusive License Agreement (Aderis Pharmaceuticals Inc)